Date Available
5-7-2014
Year of Publication
2014
Degree Name
Doctor of Nursing Practice
Committee Chair
Sharon Lock, PhD, APRN
Clinical Mentor
Paula Gisler, MSN, RN
Committee Member
Mollie Aleshire, DNP, APRN
Abstract
Purpose: The primary objective for this retrospective chart review was to evaluate provider adherence to the 2011 AHA/ASA Primary Stroke Prevention guideline of prescribing a statin to all diabetic patients for primary prevention of stroke, regardless of dyslipidemia. A second aim of this study is to identify provider facilitators and barriers to prescribing a statin therapy for primary prevention.
Methods: Using a retrospective study design, a random sample of 100 medical records of diabetic patients presenting to a university women’s health clinic within the previous year were reviewed for statin use and rationale.
Results: Of the 100 diabetic patients sampled, only 69% were currently prescribed a statin therapy. Furthermore, only one patient had a diabetic rationale for statin use. Primary stroke prevention counseling and therapy aimed at prevention of primary stroke will be completed at a future date.
Conclusion: In this clinic setting there is no documentation of adherence to the 2011 AHA/ASA Primary Stroke Prevention Guideline recommendation that statin therapy be used as a primary prevention in the diabetic population.
Recommended Citation
Hatcher, Amy L., "Primary Stroke Prevention: 3-hydroxy-3-methyl-glutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitor (statin) Use in the Diabetic Patient" (2014). DNP Projects. 22.
https://uknowledge.uky.edu/dnp_etds/22
